Searched for
GLOBAL PHARMACEUTICAL COMPANY
Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenueGland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer...- US cos see growing business interest in India as bilateral trade crosses $240 billion, says envoy GorSergio Gor, the US Ambassador, underscores the robust trust and teamwork that characterize US-India relations. With American businesses pur...
- Forget Nvidia chips, China's next big race is being slowed down by an unlikely rival: monkeysLab primate prices in China have surged over 1,000% in eight years, with a single cynomolgus macaque now costing around Rs 22 lakh. The sho...
- India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- India's big billion-dollar trade deals are done. Now comes the real testIndia has spent years negotiating free trade agreements with some of the world's biggest economies. But signing the deals was only half the...
- Uzbekistan invites Indian firms for mining, minerals push ahead of PM Modi's visitIn a bid to enhance economic ties, Uzbekistan is inviting Indian investments into its mining and metallurgy sectors, highlighting lucrative...
- Global Market: European shares climb as earnings, US-Iran diplomacy lift sentimentEuropean stocks advanced on Wednesday, driven by U.S.-Iran diplomatic talks. Mining companies led the rally as geopolitical concerns eased ...
- India Inc goes on a global shopping spree with a new wishlistIndian companies are increasingly pursuing strategic overseas acquisitions. They now focus on acquiring capabilities and technology rather ...
- Japan's Takeda bets on dengue vax to reshape India playbookTakeda Pharmaceutical's new dengue vaccine Qdenga received approval in India. The vaccine is expected to launch commercially in early 2027....
- ETMarkets Smart Talk| Large caps offer stability, but alpha lies in selective mid- and small-caps: Rakesh VyasWhile the near-term outlook remains clouded by inflation concerns and margin pressures, Rakesh Vyas, CIO & Portfolio Manager at Quest Inves...
- Govt weighs PLI 2.0 with sharper focus on high-performing sectorsIndia is planning a second phase for its production-linked incentive programme. This new phase will support high-performing sectors and red...
- India, Uzbekistan could explore FTA, says Piyush Goyal; Uzbekistan invites Indian investment in mining, rare earthsIndia and Uzbekistan aim to double bilateral trade to three billion dollars within three years. Businesses are urged to increase investment...
- ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyThe ET Health Conclave 2026 celebrated healthcare professionals and institutions. Leaders shared insights on healthcare infrastructure and ...
- India-Arab business chambers join hands to push trade & investment tiesIndia and Arab countries signed a trade and investment pact this week. The agreement aims to boost bilateral trade and business partnership...
- Sun Pharma Q1 Results: Profit rises 27% YoY to Rs 2,895 crore; revenue climbs 10.5%Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...
- Piramal Pharma to focus on policy, not Trump tariff tweets: Nandini PiramalPiramal Pharma will focus on policy actions amid tariff concerns. Its global manufacturing network offers a significant advantage. The comp...
- As we look to the next decade, I hope in the future we can further grow in generics as we transition into drug innovation: Aman Mehta, MD, Torrent PharmaceuticalsTorrent Pharma aims to become a top three Indian drug maker. The company is transitioning from generics to drug innovation for growth. Aman...
- Karnataka discusses Takeda GCC expansion, innovation partnershipsKarnataka held discussions with Takeda Pharmaceutical leaders regarding their global capability center expansion. The talks focused on digi...
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
- Sakar Healthcare posts Rs 10-crore profit in Q1Sakar Healthcare announced a substantial net profit increase for the first quarter of 2026-27. The company's revenue from operations also s...
Load More
